Clinic News

Latest in Cardiology

ACC CardiaCast: Heart Vision: Imaging and the 2025 ACC Pathway for Tricuspid Regurgitation
In this episode of Heart Vision, Dr. Purvi Parwani sits down with Dr. Rebecca T. Hahn, a leading expert in valvular heart disease and advanced cardiovascular imaging.
Studies Examine Current Treatments and Trends For Peripheral Vascular Interventions
Two studies published Nov. 10 in JACC: Cardiovascular Interventions examine current treatment options, outcomes and trends for peripheral vascular interventions (PVIs).
ACC CardiaCast: Debunking Reasons for Delayed HF Treatment: BP Too Low (No Such Thing!)
In this episode, Keith C. Ferdinand, MD, FACC, discusses why low blood pressure (BP) should not delay heart failure (HF) treatment.
Governance in Action: Updates From ACC's October Board of Trustees Meeting
ACC's October Board of Trustees (BOT) meeting was rich with strategic dialogue and forward-looking initiatives that reflect our shared commitment to advancing cardiovascular care and strengthening the ACC community.
Government Shutdown Ends With Legislation That Extends Medicare Telehealth Flexibilities
Congress passed legislation on Nov. 12 to fund the federal government, and shortly after, President Donald Trump signed the continuing resolution into law, ending the longest ever government shutdown after 43 days of gridlock.
PISCES: Fish Oil Reduces CV Event Risk in Patients on Dialysis
Patients on maintenance hemodialysis receiving daily fish oil had significantly lower rates of serious cardiovascular events than those receiving placebo, according to the PISCES trial, presented at the American Society of Nephrology Kidney Week Annual Meeting and simultaneously published Nov. 7 in NEJM.
Eagleâ€™s Eye View: Highlights from the 2025 AHA Scientific Sessions
In this weekâ€™s View, Dr. Eagle highlights several important studies presented at the recent American Heart Association Scientific Sessions.
ACCEL Lite: TACSI Trial: Dual or Single Antiplatelet Therapy After CABG in Patients With ACS
In this interview, Drs. Steven E. Nissen and Anders Jeppsson discuss â€œTACSI Trial: Dual or Single Antiplatelet Therapy After CABG in Patients With ACSâ€.
JACC Featured Science: ECG-AI For HF Risk; ANSWER-HF; NEO-MINDSET; MANIFEST-US
Featured science studies simultaneously published in JACC and presented at AHA 2025 looked at artificial intelligence applied to an electrocardiogram (ECG-AI) for heart failure (HF) risk, treatment of Chagas disease, early aspirin withdrawal in STEMI and non-ST-segment elevation acute coronary syndrome (NSTE-ACS), and safety of the pentaspline pulsed-field ablation (PFA) catheter.
Secondary Cardiovascular Prevention For Survivors of Childhood Cancer
Approximately half a million people in the United States are survivors of cancer diagnosed in childhood or adolescence. Over 50% of pediatric cancer patients have been treated with curative, but cardiotoxic, anthracycline-based therapies.